JP Stock MarketDetailed Quotes

4893 Noile-Immune Biotech

Watchlist

182
-8-4.21%

20min DelayMarket Closed Feb 14 15:30 JST

7.88BMarket Cap-6.68P/E (Static)

Noile-Immune Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Noile-Immune Biotech Q4 2024 Earnings Date

Currency：JPYFeb 14, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	2.00M	--
		-25.21%
EPS	--	-4.10	--
		+36.55%

Analyst Rating

Strong Buy

Dec 19, 2023

Noile-Immune Biotech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
Nov 14, 2024	2024/Q3	3.000M / --	--
May 14, 2024	2024/Q1	2.000M / --	--
Nov 13, 2023	2023/Q3	303.000M / --	--

DatePeriodRevenue/EstimateEarnings Call

Nov 14, 20242024/Q33.000M / ----

May 14, 20242024/Q12.000M / ----

Nov 13, 20232023/Q3303.000M / ----

--------

Unlock Free Earnings Estimates

Open Account

Noile-Immune Biotech Earnings Reports

Noile-Immune Biotech: Summary of financial results for the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)

Feb 14 03:00 ET

Noile-Immune Biotech: Notice regarding publication of earnings forecasts

Nov 14, 2024 01:30 ET

Noile-Immune Biotech: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)

Nov 14, 2024 01:30 ET

Noile-Immune Biotech: Correction Confirmation Form

Oct 14, 2024 23:07 ET

Symbol Price % Chg

See the daily top gainer.

Analysis

Analyst Rating

Updated: Dec 19, 2023

Strong Buy

Strong Buy
100.00%
Buy
0.00%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data